Structure |
Chemical Name |
CAS |
MF |
|
Linagliptin Impurity I |
|
|
|
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
|
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
|
Canagliflozin Defluoro Impurity |
|
|
|
Dapagliflozin Impurity 6 |
|
|
|
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
|
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
|
Riociguat Impurtiy 1 |
|
|
|
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
|
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
|
Dapagliflozin Impurity G |
|
|
|
Dapoxetine Impurity B |
|
|
|
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
|
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
|
Pramipexole Impurity H |
|
|
|
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
|
Vonoprazan impurity A |
|
|
|
5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
2170716-02-4 |
C22H29ClN2O5 |
|
Ibrutinib impurity D |
|
|
|
Mupirocin impurity A |
|
C26H44O9 |
|
FG-4592 intermediate7 |
1509958-19-3 |
C20H20N2O4 |
|
Milnacipran Impurity 13 |
710339-49-4 |
C12H16NO+ |
|
Urapidil Impurity A |
|
|
|
Tofacitinib Impurity I |
|
|
|
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
|
Itopride Impurity C |
141996-97-6 |
C19H24N2O4 |
|
Mirabegron Impurity |
1796931-48-0 |
C21H24N4O2S |
|
FAMOTIDINE RELATED COMPOUND B |
89268-62-2 |
C16H23N11O2S5 |
|
TIZOXANIDE GLUCURONIDE, SODIUM SALT |
221287-83-8 |
C16H14N3NaO10S |
|
Sugammadex sodium Impurity 50 |
|
|
|
Cabozantinib impurity 39 |
|
|
|
Cabozantinib impurity 53 |
|
|
|
1-(2-chloro-2-(2,4-difluorophenyl)ethyl)-1H-1,2,4-triazole |
206050-24-0 |
C10H8ClF2N3 |
|
methyl 1-phenylethanesulfonate |
883835-57-2 |
C9H12O3S |
|
Doxofylline Impurity 22 |
|
|
|
Dapoxetine impurity 61 |
|
|
|
Dapoxetine impurity 55 |
|
|
|
1-METHYLBIGUANIDE SULPHATE |
1609-00-3 |
C3H9N5 |
|
1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE |
1246815-70-2 |
C12H18ClNO3 |
|
4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid |
110611-91-1 |
C71H110NO15P |
|
Oxacillin Impurity H |
|
|
|
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
|
PeraMpanel |
380918-54-7 |
C23H15N3O |
|
Empagliflozin Impurity 79 |
|
|
|
Empagliflozin Impurity 89 |
2452301-32-3 |
C23H25ClO7 |
|
Levocarnitine Impurity F |
6490-19-3 |
C7H17ClN2O2 |
|
4,4-dimethyl-2-(2-phenylpropan-2-yl)oxazo‐ line |
874895-87-1 |
C14H19NO |
|
Formoterol Impurity 4 |
|
|
|
Roxadustat-001 |
319-57-3 |
C8H5BF4N2O2 |
|
Ornidazole Impurity 24 |
|
|
|
Olanzapine impurity ANB |
|
|
|
Pitavastatin Impurity 75 |
|
|
|
Febuxostat Impurity 100 |
|
|
|
Febuxostat Impurity 101 |
|
|
|
Febuxostat Impurity 105 |
|
|
|
(S)-10-amino-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
|
|
|
Ticagrelor Impurity 129 |
1381841-36-6 |
C15H19NO3 |
|
Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
136819-59-5 |
C13H10N2O3 |
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, 5-oxide, (6R,7R)- (9CI) |
97466-28-9 |
C18H18N8O8S3 |
|
1,3-Benzenediamine, 4-methyl-N3-[4-methyl-6-(3-pyridinyl)-2-pyrimidinyl]- |
1032314-73-0 |
C17H17N5 |
|
5-methoxy-1-methyl-1H-benzo[d]imidazole-2-sulfonic acid |
|
|
|
Teneligliptin Impurity 17 |
|
|
|
1(3H)-Isobenzofuranone, 3-(1-methylpropyl)- |
261783-87-3 |
C12H14O2 |
|
Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-hydroxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester |
1062642-68-5 |
C32H30F5N3O5 |
|
2-Oxazolidinone, 5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-, (5S)- |
2514942-86-8 |
C13H15NO4 |
|
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-, (5S,6E)- |
1803023-43-9 |
C22H26FN3O6S |
|
Drug impurity detection and analysis |
|
|
|
1-Pyrrolidinecarboxamide, N-[5-[(2S)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)- |
2409590-08-3 |
C21H22F2N6O2 |
|
Sertraline Impurity 20 |
1498236-91-1 |
C16H14Cl2O |
|
Budesonide Impurity 21 |
|
|
|
2H-3-Benzazepin-2-one, 3-(3-bromopropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy- |
1192174-72-3 |
C15H20BrNO3 |
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-nitro-, ethyl ester, (3R,4R,5S)- |
949164-64-1 |
C16H26N2O6 |
|
Peramivir Impurity 55 |
|
|
|
Peramivir Impurity 60 |
|
|
|
Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)- |
2408196-94-9 |
C8H16O3 |
|
Loratadine EP Impurity L |
|
|
|
Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI) |
151003-82-6 |
C24H34O6 |
|
3-(4-TRIFLUOROMETHYL-PHENYL)-PROPAN-1-OL |
180635-74-9 |
C10H11F3O |
|
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
|
|
|
(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER |
96914-67-9 |
C9H13NO2 |
|
Nicergoline Impurity 7 |
|
|
|
N,N'-Bis(2-Hydroxyethyl)propane-1,3-diamine |
10563-27-6 |
C7H18N2O2 |
|
4-((3-hydroxy-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
|
2-oxo-2-((6S,8S,9S,10R,13S,14S,17S)-6,10,13-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl acetate |
|
|
|
Tirofiban Impurity 79 |
158808-85-6 |
C21H34N2O5S |
|
Brivaracetam Impurity 47 |
2755924-55-9 |
|
|
4-((3-amino-1-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
|
(Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine |
94213-23-7 |
C9H7Cl2N5 |
|
Perampanel Impurity ABCDEFGHJKL |
|
|
|
Ethyl-3-acetoxy-2-butenoat |
29214-62-8 |
C8H12O4 |
|
2-(Brommethyl)-2-(2,4-dichlorphenyl)-1,3-dioxolan-4-methanol |
68751-57-5 |
C11H11BrCl2O3 |
|
INDEX NAME NOT YET ASSIGNED |
2511244-96-3 |
C27H36N2O6 |
|
Oseltamivir Impurity 91 |
|
|
|
Oseltamivir Impurity 80 |
|
|
|
Oseltamivir Impurity 72 |
|
|
|
4(1H)-Quinazolinone, 6,8-dibromo-3-cyclohexyl-2,3-dihydro- |
2512203-87-9 |
C14H16Br2N2O |
|
Linagliptin impurity KH-3 |
2279114-27-9 |
C30H37N7O6 |
|
11β,21-Dihydroxypregna-1,4,16-trien-3,20-dion-21-acetat |
3044-42-6 |
C23H28O5 |
|
3-[3-(tert-Butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazolmonomaleat |
57073-55-9 |
C17H28N4O7S |
|
Ampicillin Impurity U |
|
|